Rapid Therapeutic Science Laboratories, Inc.
RTSL
$0.0074
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 59.50K | -23.70K | -1.79M | -3.06M | -3.41M |
| Total Depreciation and Amortization | 24.00K | 24.00K | 24.00K | 87.30K | 65.50K |
| Total Amortization of Deferred Charges | 504.40K | 1.17M | 1.76M | 2.29M | 2.49M |
| Total Other Non-Cash Items | -1.08M | -1.79M | -1.34M | -1.19M | -1.31M |
| Change in Net Operating Assets | -71.10K | 129.10K | 200.00K | 523.30K | 275.00K |
| Cash from Operations | -566.50K | -494.00K | -1.15M | -1.35M | -1.90M |
| Capital Expenditure | 315.60K | -4.00K | -39.20K | -530.20K | -607.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 315.60K | -4.00K | -39.20K | -530.20K | -607.60K |
| Total Debt Issued | 388.20K | 794.80K | 1.29M | 1.06M | 2.61M |
| Total Debt Repaid | -287.20K | -312.10K | -287.90K | -98.50K | -39.40K |
| Issuance of Common Stock | 40.00K | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 141.00K | 482.70K | 998.40K | 962.00K | 2.57M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -110.00K | -15.40K | -192.50K | -919.70K | 64.30K |